neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and other Transcranial Magnetic Stimulation systems for clinical practice.
Read MoreAwareUM's unified and closed-loop review workflow is critical to maximize team productivity and enhance stakeholder communication and collaboration
Read MoreRegional Cancer Care Associates is pleased to announce the recognition of John Theurer Cancer Center as the #1 Cancer Program in New Jersey by U.S. News and World Report
Read MoreComprehensive Back-to-School Event on Saturday, July 20, 2024, Will Feature Life-Saving Cardiac Screenings Alongside Free Haircuts, Supplies, Meals, and More
Read MoreLifesciences Magazine: Battling Diabetes! Exclusive Interview with the Glen Travers (Co-founder of Diabetology Limited), Leading Biopharma Company Pushing Boundaries
Read MoreAchieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC Accreditation and NCQA Certification for Credentials Verification Organization (CVO).
Read More